会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Peptide inhibitors of a phosphotyrosine-binding domain containing protein
    • 含有蛋白质的磷酸酪氨酸结合结构域的肽抑制剂
    • US6028053A
    • 2000-02-22
    • US51934
    • 1998-04-22
    • Peter van der GeerSandra WileyGerald GishAnthony PawsonKazunori Toma
    • Peter van der GeerSandra WileyGerald GishAnthony PawsonKazunori Toma
    • A61K38/00C07K14/71C07K14/715A61K38/08A61K38/10A61K38/12C07K7/06C07K7/08
    • C07K14/71C07K14/715A61K38/00
    • A peptide of the formula (I): X.sup.1 -A.sup.1 -A.sup.2 -X.sup.2 -Asn-X.sup.3 -X.sup.4 -P.Tyr-X.sup.5 -X.sup.6 -X.sup.7 -X.sup.8, wherein X.sup.1 represents Lys, Arg, His, Ser, Thr, Tyr, Asn, Leu, Val or Glu, A.sup.1 represents Trp, Leu, Ala, Ser, Ile, Glu, Met, Gly, Cys, Phe, Pro or Val, and A.sup.2 represents Ala, Val, Leu, Ile, Ser, Met, Phe, Gly, Cys, Trp or Pro, X.sup.2 represents Glu, Asn, Tyr, Thr, Ser, Asp or Ile, X.sup.3 represents Pro, Met, Trp, Phe, Ala, Lys, Val, Leu, Ile, Gly or Ser, X.sup.6 represents Ser, Thr, Tyr, Asn, Glu, Met, Ala, Leu, Val or Gly, X.sup.7 represents Asp, Glu, Ala, Val, Leu, Ile, Gly, Cys, Phe, Trp, Met, Pro, Ser or Asn and X.sup.8 which may be present or absent represents Phe, Trp, Pro, Leu, Ala, Val, Ile, Gly, Cys, Met, Asp, Ser or Arg which interferes with the interaction of a PTB domain containing protein with a PTB domain binding site, and truncations and analogues of the peptide.
    • PCT No.PCT / US96 / 17080 Sec。 371日期:1998年4月22日 102(e)日期1998年4月22日PCT 1996年10月24日PCT公布。 公开号WO97 / 15318 PCT 日期:1997年5月1日一种式(I)的肽:X1-A1-A2-X2-Asn-X3-X4-P.Tyr-X5-X6-X7-X8,其中X1表示Lys,Arg,His,Ser, Thr,Tyr,Asn,Leu,Val或Glu,A1表示Trp,Leu,Ala,Ser,Ile,Glu,Met,Gly,Cys,Phe,Pro或Val,A2表示Ala,Val,Leu,Ile,Ser ,Met,Phe,Gly,Cys,Trp或Pro,X2表示Glu,Asn,Tyr,Thr,Ser,Asp或Ile,X3表示Pro,Met,Trp,Phe,Ala,Lys,Val,Leu,Ile,Gly 或Ser,X 6表示Ser,Thr,Tyr,Asn,Glu,Met,Ala,Leu,Val或Gly,X7表示Asp,Glu,Ala,Val,Leu,Ile,Gly,Cys,Phe,Trp,Met,Pro 可能存在或不存在的Ser或Asn和X8表示干扰与含有PTB结构域的蛋白质相互作用的Phe,Trp,Pro,Leu,Ala,Val,Ile,Gly,Cys,Met,Asp,Ser或Arg PTB结构域结合位点,以及肽的截短和类似物。
    • 4. 发明授权
    • Dual-terminal amide hydrogelling agent
    • 双末端酰胺水凝胶剂
    • US08633022B2
    • 2014-01-21
    • US13201111
    • 2010-02-23
    • Hitoshi TamiakiKeishiro OgawaKazunori Toma
    • Hitoshi TamiakiKeishiro OgawaKazunori Toma
    • C12N5/00C07C239/00
    • C07C235/48C12N5/0068C12N2533/30
    • The invention relates to a benzamide derivative represented by formula (1): wherein k1 represents an integer from 0-4, m1 represents an integer from 1-100, and n1 represents an integer from 1-6. In addition, R1 represents a hydrocarbon group with 8-22 carbon atoms bonded to an oxygen atom wherein the oxygen atom is bonded to the adjacent ring of said derivative; R2 represents H or a hydrocarbon group with 1-22 carbon atoms bonded to an oxygen atom wherein the oxygen atom is bonded to the adjacent ring of said derivative; R3 represents H or a hydrocarbon group with 1-22 carbon atoms bonded to an oxygen atom wherein the oxygen atom is bonded to the adjacent ring of said derivative; and R2 and R3 are not H at the same time.
    • 本发明涉及由式(1)表示的苯甲酰胺衍生物:其中k1表示0-4的整数,m1表示1-100的整数,n1表示1-6的整数。 此外,R 1表示与氧原子键合的碳原子数为8〜22的烃基,其中氧原子与所述衍生物的相邻环结合; R2表示H或与氧原子键合的具有1-22个碳原子的烃基,其中氧原子键合到所述衍生物的相邻环上; R3表示H或与氧原子键合的具有1-22个碳原子的烃基,其中氧原子与所述衍生物的相邻环结合; R2和R3不同时为H。